Literature DB >> 25063800

Ozone-induced airway epithelial cell death, the neurokinin-1 receptor pathway, and the postnatal developing lung.

Shannon R Murphy1, Karen L Oslund2, Dallas M Hyde3, Lisa A Miller3, Laura S Van Winkle4, Edward S Schelegle5.   

Abstract

Children are uniquely susceptible to ozone because airway and lung growth continue for an extensive period after birth. Early-life exposure of the rhesus monkey to repeated ozone cycles results in region-specific disrupted airway/lung growth, but the mediators and mechanisms are poorly understood. Substance P (SP), neurokinin-1 receptor (NK-1R); and nuclear receptor Nur77 (NR4A1) are signaling pathway components involved in ozone-induced cell death. We hypothesize that acute ozone (AO) exposure during postnatal airway development disrupts SP/NK-1R/Nur77 pathway expression and that these changes correlate with increased ozone-induced cell death. Our objectives were to 1) spatially define the normal development of the SP/NK-1R/Nur77 pathway in conducting airways; 2) compare how postnatal age modulates responses to AO exposure; and 3) determine how concomitant, episodic ozone exposure modifies age-specific acute responses. Male infant rhesus monkeys were assigned at age 1 mo to two age groups, 2 or 6 mo, and then to one of three exposure subgroups: filtered air (FA), FA+AO (AO: 8 h/day × 2 days), or episodic biweekly ozone exposure cycles (EAO: 8 h/day × 5 days/14-day cycle+AO). O3 = 0.5 ppm. We found that 1) ozone increases SP/NK-1R/Nur77 pathway expression in conducting airways, 2) an ozone exposure cycle (5 days/cycle) delivered early at age 2 mo resulted in an airway that was hypersensitive to AO exposure at the end of 2 mo, and 3) continued episodic exposure (11 cycles) resulted in an airway that was hyposensitive to AO exposure at 6 mo. These observations collectively associate with greater overall inflammation and epithelial cell death, particularly in early postnatal (2 mo), distal airways.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  NK-1R; bronchial epithelium; lung; neurokinin; substance P

Mesh:

Substances:

Year:  2014        PMID: 25063800      PMCID: PMC4166783          DOI: 10.1152/ajplung.00324.2013

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  48 in total

Review 1.  Development of airway epithelium. Patterns of expression for markers of differentiation.

Authors:  C Plopper; J St George; W Cardoso; R Wu; K Pinkerton; A Buckpitt
Journal:  Chest       Date:  1992-03       Impact factor: 9.410

2.  A comparison of terminal airway remodeling in chronic daily versus episodic ozone exposure.

Authors:  B C Barr; D M Hyde; C G Plopper; D L Dungworth
Journal:  Toxicol Appl Pharmacol       Date:  1990-12       Impact factor: 4.219

3.  Reproducibility of retrospective assessment of outdoor time-activity patterns as an individual determinant of long-term ambient ozone exposure.

Authors:  N Künzli; T Kelly; J Balmes; I B Tager
Journal:  Int J Epidemiol       Date:  1997-12       Impact factor: 7.196

Review 4.  Postnatal lung development and its impairment by glucocorticoids.

Authors:  S A Tschanz; P H Burri
Journal:  Pediatr Pulmonol Suppl       Date:  1997

5.  Airway inflammation in smokers and nonsmokers with varying responsiveness to ozone.

Authors:  A Torres; M J Utell; P E Morow; K Z Voter; J C Whitin; C Cox; R J Looney; D M Speers; Y Tsai; M W Frampton
Journal:  Am J Respir Crit Care Med       Date:  1997-09       Impact factor: 21.405

6.  Delineation of the endocytic pathway of substance P and its seven-transmembrane domain NK1 receptor.

Authors:  E F Grady; A M Garland; P D Gamp; M Lovett; D G Payan; N W Bunnett
Journal:  Mol Biol Cell       Date:  1995-05       Impact factor: 4.138

7.  Neonatal capsaicin treatment increases the severity of ozone-induced lung injury.

Authors:  A Sterner-Kock; K R Vesely; M Y Stovall; E S Schelegle; J F Green; D M Hyde
Journal:  Am J Respir Crit Care Med       Date:  1996-01       Impact factor: 21.405

8.  Differentiation of tracheal epithelium during fetal lung maturation in the rhesus monkey Macaca mulatta.

Authors:  C G Plopper; J L Alley; A J Weir
Journal:  Am J Anat       Date:  1986-01

Review 9.  Cholinergic and neurogenic mechanisms in obstructive airways disease.

Authors:  E R Bleecker
Journal:  Am J Med       Date:  1986-11-14       Impact factor: 4.965

10.  Development of PGP 9.5- and calcitonin gene-related peptide-like immunoreactivity in organ cultured fetal rat lungs.

Authors:  S P Sorokin; M Ebina; R F Hoyt
Journal:  Anat Rec       Date:  1993-05
View more
  5 in total

1.  Integrative analysis reveals mouse strain-dependent responses to acute ozone exposure associated with airway macrophage transcriptional activity.

Authors:  Adelaide Tovar; Wesley L Crouse; Gregory J Smith; Joseph M Thomas; Benjamin P Keith; Kathryn M McFadden; Timothy P Moran; Terrence S Furey; Samir N P Kelada
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-11-10       Impact factor: 6.011

2.  Targeting nuclear receptor NR4A1-dependent adipocyte progenitor quiescence promotes metabolic adaptation to obesity.

Authors:  Yang Zhang; Alexander J Federation; Soomin Kim; John P O'Keefe; Mingyue Lun; Dongxi Xiang; Jonathan D Brown; Matthew L Steinhauser
Journal:  J Clin Invest       Date:  2018-10-02       Impact factor: 14.808

3.  Modulation of the EMT/MET Process by E-Cadherin in Airway Epithelia Stress Injury.

Authors:  Li Han; Huaiqing Luo; Wenjie Huang; Jiang Zhang; Di Wu; Jinmei Wang; Jiao Pi; Chi Liu; Xiangping Qu; Huijun Liu; Xiaoqun Qin; Yang Xiang
Journal:  Biomolecules       Date:  2021-04-30

Review 4.  Role of CD1d- and MR1-Restricted T Cells in Asthma.

Authors:  Chiaki Iwamura; Toshinori Nakayama
Journal:  Front Immunol       Date:  2018-08-28       Impact factor: 7.561

Review 5.  Transcriptional Effects of Ozone and Impact on Airway Inflammation.

Authors:  Sharon Mumby; Kian Fan Chung; Ian M Adcock
Journal:  Front Immunol       Date:  2019-07-10       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.